FIGURE 1.
Kaplan–Meier survival curves and life tables for the occurrence of the (A) primary endpoints (all-cause death, or non-fatal MI or non-fatal stroke or coronary revascularization or hospitalization for heart failure or AF) and the secondary endpoints, (B) all-cause mortality and (C) cardiovascular mortality in the tertiles of sclerostin levels.